Akebia Therapeutics Resubmits NDA For Vadadustat To FDA

RTTNews | il y a 679
Akebia Therapeutics Resubmits NDA For Vadadustat To FDA

(RTTNews) - Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for vadadustat for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.

Vadadustat, Akebia's investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is currently approved for use in 35 countries.

Based on standard NDA resubmission review timelines, a letter from the FDA acknowledging that the resubmission is complete, classifying the resubmission, and setting the PDUFA date is expected in 30 days. Akebia expects the FDA to set a PDUFA date of six months from the date of submission.

For More Such Health News, visit rttnews.com

read more
Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3

Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3

Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday that the company expects to resubmit its New Drug Application (NDA) for vadadustat as a treatment for anemia due to chronic kidney disease in adult patients on dialysis by the end of the third quarter of 2023.
RTTNews | il y a 714
European Shares Seen Higher At Open

European Shares Seen Higher At Open

European shares are seen opening higher on Friday after U.S. reciprocal tariffs took effect at midnight on Thursday.
RTTNews | il y a 55 minutes
NZ Dollar Rises Against Majors

NZ Dollar Rises Against Majors

The New Zealand dollar strengthened against other major currencies in the Asian session on Friday.
RTTNews | il y a 1h 8min
Sensex, Nifty Edge Lower On Tariff Concerns

Sensex, Nifty Edge Lower On Tariff Concerns

Indian shares were moving lower on Friday as U.S. President Donald Trump ruled out trade talks with India and Prime Minister Modi said he will never compromise on farmers' interests.
RTTNews | il y a 2h 6min
Australian Market Trims Early Losses In Mid-market

Australian Market Trims Early Losses In Mid-market

The Australian stock market is trimming its early losses in mid-market moves on Friday, extending the slight losses in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,850 level, with weakness in financial and technology stocks partially offset by gains in mining stocks.
RTTNews | il y a 3h 17min
Asian Markets Mixed Amid Tariff Caution

Asian Markets Mixed Amid Tariff Caution

Asian stock markets are trading mixed on Friday, following the mixed cues from Wall Street overnight, as uncertainty continues over US reciprocal tariffs despite the tariff's kicking in on Thursday. Market uncertainty is created by the pressure tactics exerted by the US by constantly altering tariffs. Asian markets ended mostly higher on Thursday.
RTTNews | il y a 3h 20min
Sensex, Nifty Set To Open Lower On Trade Concerns

Sensex, Nifty Set To Open Lower On Trade Concerns

Indian shares look set to open on a sluggish note Friday as U.S. President has ruled out any possibility of trade negotiations with India and Prime Minister Narendra Modi said India would not compromise on the interests of its farmers, fishermen or livestock rearers, even if it meant paying "a heavy personal price."
RTTNews | il y a 4h 3min
Thai Stock Market May Spin Its Wheels On Friday

Thai Stock Market May Spin Its Wheels On Friday

The Thai stock market has moved higher in four straight sessions, gathering almost 50 points or 4.1 percent along the way. The Stock Exchange of Thailand now sits just above the 1,265-point plateau although it may be stuck in neutral on Friday.
RTTNews | il y a 4h 36min